Non-viral vectors have emerged as a promising alternative to viral gene delivery systems due to their safer profile. Among non-viral vectors, recently, niosomes have shown favorable properties for gene delivery, including low toxicity, high stability, and easy production. The three main components of niosome formulations include a cationic lipid that is responsible for the electrostatic interactions with the negatively charged genetic material, a non-ionic surfactant that enhances the long-term stability of the niosome, and a helper component that can be added to improve its physicochemical properties and biological performance. This review is aimed at providing recent information about niosome-based non-viral vectors for gene delivery purposes. Specially, we will discuss the composition, preparation methods, physicochemical properties, and biological evaluation of niosomes and corresponding nioplexes that result from the addition of the genetic material onto their cationic surface. Next, we will focus on the in situ application of such niosomes to deliver the genetic material into immune-privileged tissues such as the brain cortex and the retina. Finally, as future perspectives, non-invasive administration routes and different targeting strategies will be discussed.
Oxidative damage has been linked to a number of diseases. Oleuropein (OLE), a natural occurring polyphenol from olive leaves (Olea europaea L.), is known to be a potent antioxidant compound with inherent instability and compromised bioavailability. Therefore, in this work, nanostructured lipid carriers (NLCs) were proposed for OLE encapsulation to protect and improve its antioxidant efficacy. The lipid matrix, composed of olive oil and Precirol, was optimized prior to OLE encapsulation. The characterization of the optimized oleuropein-loaded NLCs (NLC-OLE) showed a mean size of 150 nm, a zeta potential of −21 mV, an encapsulation efficiency of 99.12%, sustained release profile, and improved radical scavenging activity. The cellular in vitro assays demonstrated the biocompatibility of the NLCs, which were found to improve and maintain OLE antioxidant efficacy in the A549 and CuFi-1 lung epithelial cell lines, respectively. Overall, these findings suggest a promising potential of NLC-OLE to further design a pulmonary formulation for OLE delivery in lung epithelia.
In recent years, progress in nanotechnology provided new tools to treat cancer more effectively. Advances in biomaterials tailored for drug delivery have the potential to overcome the limited selectivity and side effects frequently associated with traditional therapeutic agents. While autophagy is pivotal in determining cell fate and adaptation to different challenges, and despite the fact that it is frequently dysregulated in cancer, antitumor therapeutic strategies leveraging on or targeting this process are scarce. This is due to many reasons, including the very contextual effects of autophagy in cancer, low bioavailability and non-targeted delivery of existing autophagy modulatory compounds. Conjugating the versatile characteristics of nanoparticles with autophagy modulators may render these drugs safer and more effective for cancer treatment. Here, we review current standing questions on the biology of autophagy in tumor progression, and precursory studies and the state-of-the-art in harnessing nanomaterials science to enhance the specificity and therapeutic potential of autophagy modulators.
Nanodiamonds
(NDs) are promising materials for gene delivery because
of their unique physicochemical and biological features, along with
their possibility of combination with other nonviral systems. Our
aim was to evaluate the biophysical performance of NDs as helper components
of niosomes, named nanodiasomes, to address a potential nonviral gene
delivery nanoplatform for therapeutic applications in central nervous
system (CNS) diseases. Nanodiasomes, niosomes, and their corresponding
complexes, obtained after genetic material addition at different ratios
(w/w), were evaluated in terms of physicochemical properties, cellular
uptake, intracellular disposition, biocompatibility, and transfection
efficiency in HEK-293 cells. Nanodiasomes, niosomes, and complexes
fulfilled the physicochemical features for gene therapy applications.
Biologically, the incorporation of NDs into niosomes enhanced 75%
transfection efficiency (
p
< 0.001) and biocompatibility
(
p
< 0.05) to values over 90%, accompanied by
a higher cellular uptake (
p
< 0.05). Intracellular
trafficking analysis showed higher endocytosis via clathrins (
p
< 0.05) in nanodiaplexes compared with nioplexes, followed
by higher lysosomal colocalization (
p
< 0.05),
that coexisted with endosomal escape properties, whereas endocytosis
mediated by caveolae was the most efficient pathway in the case of
nanodiaplexes. Moreover, studies in CNS primary cells revealed that
nanodiaplexes successfully transfected neuronal and retinal cells.
This proof-of-concept study points out that ND integration into niosomes
represents an encouraging nonviral nanoplatform strategy for the treatment
of CNS diseases by gene therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.